Rheumatoid Arthritis - Treatment
A slides set on RA Treatment options with MTX teaching slides
The pros and cons of Private Practice vs. Academic Medicine. - submitted by Kathryn Dao, MD
Distinguishing features between the 2021 ACR and 2022 EULAR RA treatment guidelines
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.